Phase II Study of Nivolumab in Combination With Radiation Therapy as Definitive Treatment for Patients With Locally Advanced, Unresectable Head and Neck Mucosal Melanoma.

NCT03758729 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Internal Issues

Conditions

Melanoma

Interventions

DRUG: Nivolumab
RADIATION: Radiation Therapy

Sponsor

Samsung Medical Center